Primary aldosteronism
BMJ
.
2022 Apr 20:377:e065250.
doi: 10.1136/bmj-2021-065250.
Authors
Kay Weng Choy
1
,
Peter J Fuller
2
3
4
,
Grant Russell
5
,
Qifu Li
6
,
Marianne Leenaerts
7
,
Jun Yang
8
3
4
Affiliations
1
Department of Pathology, Northern Health, Epping, Australia.
2
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia.
3
Department of Endocrinology, Monash Health, Clayton, Australia.
4
Department of Medicine, Monash University, Clayton, Australia.
5
Department of General Practice, Monash University, Clayton, Australia.
6
Department of Endocrinology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
7
Governing Board, Primary Aldosteronism Foundation (primaryaldosteronism.org).
8
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Australia jun.yang@hudson.org.au.
PMID:
35443988
DOI:
10.1136/bmj-2021-065250
No abstract available
MeSH terms
Aldosterone
Humans
Hyperaldosteronism* / complications
Hyperaldosteronism* / diagnosis
Hypertension* / diagnosis
Substances
Aldosterone